Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
JAMES BASTA Insider Profile
4 Followers
JAMES BASTA, CLO at Kura Oncology, holds ― shares in Kura Oncology (Ticker: KURA), holds 81.57K shares in Intellia Therapeutics (Ticker: NTLA). Most recently, JAMES BASTA ― shares of Kura Oncology on ― for an estimated value of ―.
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+33.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that JAMES BASTA holds in companies
Most Profitable Insider Trade
The most profitable trade made by JAMES BASTA
JAMES BASTA's Trading History
Kura Oncology
―
CLO
―
―
Intellia Therapeutics
Mar 05, 2024
EVP & GC
Uninformative Buy
―
$1.13M
List of latest transactions for each holding click on a transaction to see JAMES BASTA's performance on stock
You May Also Like
JAMES BASTA insider profile FAQ
What is the percentage of profitable transactions made by JAMES BASTA?
The percentage of profitable transactions made by JAMES BASTA is 100%.
What is the average return per transaction made by JAMES BASTA?
The average return per transaction made by JAMES BASTA is 33.90%.
What stocks does JAMES BASTA hold?
JAMES BASTA holds: KURA, NTLA stocks.
What was JAMES BASTA’s latest transaction?
JAMES BASTA latest transaction was an Uninformative Buy of ―.
What was JAMES BASTA's most profitable transaction?
JAMES BASTA’s most profitable transaction was an Informative Sell of NTLA stock on March 5, 2024. The return on the trade was 44.60%.
What is JAMES BASTA's role in Kura Oncology?
JAMES BASTA's role in Kura Oncology is CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.